123 related articles for article (PubMed ID: 12544765)
21. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
Carlsen NL
Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115
[TBL] [Abstract][Full Text] [Related]
22. Screening for neuroblastoma and age-specific incidence.
Moe PJ
Acta Paediatr; 1999 Apr; 88(4):362-4. PubMed ID: 10342530
[No Abstract] [Full Text] [Related]
23. Parental anxiety and neuroblastoma screening of infants.
Sawada T
Pediatr Hematol Oncol; 1994; 11(2):139-40. PubMed ID: 8204438
[No Abstract] [Full Text] [Related]
24. Is the mass screening for neuroblastoma ineffective?
Nishi M; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hatae Y; Takeda T
J Exp Clin Cancer Res; 2003 Dec; 22(4):673-6. PubMed ID: 15053313
[TBL] [Abstract][Full Text] [Related]
25. Neuroblastoma screening at one year of age.
Schilling FH; Spix C; Berthold F; Erttmann R; Fehse N; Hero B; Klein G; Sander J; Schwarz K; Treuner J; Zorn U; Michaelis J
N Engl J Med; 2002 Apr; 346(14):1047-53. PubMed ID: 11932471
[TBL] [Abstract][Full Text] [Related]
26. Incidence of neuroblastoma in Sapporo city.
Nishi M; Miyake H; Takeda T; Shimada M; Takasugi N; Sato Y; Hanai J
J Pediatr Surg; 1990 May; 25(5):545-6. PubMed ID: 2191108
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of neuroblastoma by qualitative and quantitative determination of catecholamine metabolites in urine.
Gitlow SE; Bertani LM; Rausen A; Gribetz D; Dziedzic SW
Cancer; 1970 Jun; 25(6):1377-83. PubMed ID: 5422912
[No Abstract] [Full Text] [Related]
28. Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany.
Schilling FH; Spix C; Berthold F; Erttmann R; Sander J; Treuner J; Michaelis J
Cancer Lett; 2003 Jul; 197(1-2):19-28. PubMed ID: 12880955
[TBL] [Abstract][Full Text] [Related]
29. Past and future of neuroblastoma screening in Japan.
Sawada T
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
[TBL] [Abstract][Full Text] [Related]
30. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group.
Sawada T; Hirayama M; Nakata T; Takeda T; Takasugi N; Mori T; Maeda K; Koide R; Hanawa Y; Tsunoda A
Lancet; 1984 Aug; 2(8397):271-3. PubMed ID: 6146820
[TBL] [Abstract][Full Text] [Related]
31. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
Takeda T; Shimada M; Iizuka S; Takasugi N
Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
[TBL] [Abstract][Full Text] [Related]
32. [Recommended methods for the determination of catecholamines and their metabolites in urine. Significance of results in the diagnosis and follow-up of pheochromocytoma and neuroblastoma].
Revol A; Comoy E; Forzy G; Garnier JP; Gerhardt MF; Hirth C; Jacob N; Mathieu P; Patricot MC; Peyrin L
Ann Biol Clin (Paris); 1994; 52(9):625-37. PubMed ID: 7872511
[TBL] [Abstract][Full Text] [Related]
33. Neuroblastoma screening in early life.
Collins MH
N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12227370
[No Abstract] [Full Text] [Related]
34. Biologic markers in neuroblastoma.
Maurus R; Otten J
Recent Results Cancer Res; 1979; 67():78-84. PubMed ID: 451325
[No Abstract] [Full Text] [Related]
35. Screening of infants and mortality due to neuroblastoma.
Woods WG; Gao RN; Shuster JJ; Robison LL; Bernstein M; Weitzman S; Bunin G; Levy I; Brossard J; Dougherty G; Tuchman M; Lemieux B
N Engl J Med; 2002 Apr; 346(14):1041-6. PubMed ID: 11932470
[TBL] [Abstract][Full Text] [Related]
36. Mass screening of neuroblastoma in Sapporo City, Japan.
Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
[TBL] [Abstract][Full Text] [Related]
37. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1986 Dec; 16(4):351-5. PubMed ID: 3795531
[TBL] [Abstract][Full Text] [Related]
38. Screening for neuroblastoma in children.
Morris JK
J Med Screen; 2002; 9(2):56. PubMed ID: 12133921
[No Abstract] [Full Text] [Related]
39. Disomy 1 with terminal 1p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants.
Kaneko Y; Kobayashi H; Maseki N; Nakagawara A; Sakurai M
Int J Cancer; 1999 Jan; 80(1):54-9. PubMed ID: 9935230
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis and treatment of a tumor secreting catecholamines in a child 7 months old].
Desparmet J; Dubousset AM; Gaudiche O; Couturier C; Saint-Maurice C
Ann Fr Anesth Reanim; 1982; 1(5):527-9. PubMed ID: 7184349
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
